Argireline (Acetyl Hexapeptide-8) – The Clinically Proven Peptide for Expression Line Reduction
A safe, topical alternative to botulinum toxin – relaxes facial muscles, reduces wrinkle depth by up to 30% in 30 days, and is trusted by leading global brands.
Product Overview
Argireline (INCI: Acetyl Hexapeptide-8) is a synthetic peptide that mimics the mechanism of botulinum toxin (Botox) – without the needles, side effects, or loss of natural expression.【1†L18-L20】 It is a globally recognised, highly effective anti‑wrinkle ingredient used in premium skincare products by brands such as SK‑II and Estée Lauder.【1†L18-L20】
Argireline works by competing with SNAP‑25 to bind to vesicle‑associated membrane protein (VAMP), thereby inhibiting the formation of the SNARE complex – the molecular machinery responsible for acetylcholine vesicle release.【1†L23-L26】 This reduces neurotransmitter exocytosis, weakens muscle contractions, and visibly softens expression lines on the forehead, crow's feet, and around the mouth.【1†L26-L27】
| Benefit | Mechanism / Data |
|---|---|
| 🧬 Topical Botox alternative | Inhibits SNARE complex formation, reduces acetylcholine release, relaxes facial muscles【1†L23-L27】 |
| ✨ Clinically proven wrinkle reduction | 30% reduction in wrinkle depth in 30 days (10% Argireline emulsion)* |
| 📊 High responder rate | 48.9% of users showed significant anti‑wrinkle improvement (score ≥3) after 4 weeks** |
| 👁️ Visible crow's feet improvement | Reduced wrinkle number, depth, length, and total volume (clinical imaging confirmed) |
| 🌿 Safe & well‑tolerated | No side effects, no muscle paralysis, preserves natural facial expression【1†L18-L20】 |
| 🧴 Trusted by global brands | Used in SK‑II, Estée Lauder, and other premium anti‑aging lines【1†L18-L20】 |
Clinical Efficacy Data
Study 1: 30‑Day Wrinkle Depth Reduction
-
Method: 10% Argireline emulsion applied twice daily for 30 days
-
Result: Wrinkle depth decreased by 30% (vs. placebo – no significant change)【3†L1-L4】
Study 2: 4‑Week Clinical Trial (n=60, 3:1 ratio)
-
Method: Argireline vs. placebo applied twice daily for 4 weeks【3†L6-L8】
-
Result: 48.9% of Argireline‑treated subjects achieved significant anti‑wrinkle improvement (score ≥3), vs. 0% in placebo group【3†L9-L10】
Objective Measurements (Skin‑Visioline VL 650®):
-
Wrinkle count: 14 → 7 (↓50%)
-
Average depth: 60 μm → 56 μm
-
Total volume: 3.02 mm³ → 1.73 mm³ (↓43%)
-
Total area: 50.26 mm² → 31.24 mm² (↓38%)
-
Total length: 32 mm → 17 mm (↓47%)【5†L12-L19】
| Parameter | Value |
|---|---|
| INCI Name | Acetyl Hexapeptide-8 |
| Appearance | White to off‑white powder |
| Solubility | Water‑soluble |
| Recommended dosage | 2 – 10% (5‑10% for intensive treatment) |
| Formulation pH | 4.0 – 7.0 |
| Addition temperature | <50°C (cool‑down phase) |
| Applications | Anti‑wrinkle serums, eye creams, firming lotions, facial masks |
Why Formulators Choose Argireline
✅ Proven mechanism – clinically validated peptide that delivers visible results
✅ Botox‑like action, topical application – no injections, no side effects
✅ Preserves natural expression – relaxes muscles without freezing the face
✅ Premium brand recognition – used by SK‑II, Estée Lauder, and other luxury houses
✅ Easy to formulate – water‑soluble, stable at pH 4‑7
Formulation Guidelines
-
Dosage: 2 – 10% (5‑10% for optimal anti‑wrinkle efficacy)
-
Addition: Add to water phase during cool‑down (<50°C)
-
pH: 4.0 – 7.0
-
Applications:
-
Anti‑wrinkle serums & essences
-
Eye contour creams (crow's feet)
-
Forehead & frown line treatments
-
Firming & lifting formulas
-
